Personal profile
Overview
I am a Consultant in Genomic Medicine and an Honorary Senior Lecturer.
I graduated from the University of Sheffield in 2008. I undertook my foundation training and core medical training in South Yorkshire before moving to Liverpool in 2012 to start my specialty training in Clinical Genetics. I began my research, which is focused on the genetics of inherited cardiac conditions, in 2014. My main area of interest is the inherited arrhythmia syndrome Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) which is predominantly caused by variants in the cardiac ryanodine receptor (RYR2) gene. I completed my PhD, which was funded by a BHF Clinical Research Training Fellowship, in 2019. My PhD involved modelling a novel RYR2 variant using human induced pluripotent stem cells. In both 2015 and 2017 I spent time in Israel in the laboratory of Prof Gepstein who is a world leading expert in the field of modelling genetic heart conditions using human induced pluripotent stem cells. During my PhD I also had the opportunity to spend time in Prof Pinto’s laboratory at the UMC in Amsterdam. In 2019 I took up the position of NIHR Clinical Lecturer at the University of Manchester and in 2023 I was appointed as a Consultant in Genomic Medicine at Manchester University NHS Foundation Trust.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling
Hopton, C., Newman, W., Brown, B. D., Kimber, S., Venetucci, L. & Gepstein, L., 10 Apr 2022, In: Physiological Reports. 10, 8, e15265.Research output: Contribution to journal › Article › peer-review
Open AccessFile84 Downloads (Pure) -
Pathogenic intronic splice-affecting variants in MYBPC3 in three patients with hypertrophic cardiomyopathy
Newman, W., Wood, K., Thomas, H., Ellingford, J., O'Keefe, R., Hopton, C. & Eden, J., 2 Jun 2021, In: Cardiogenetics. 11, 2, p. 73-83Research output: Contribution to journal › Article › peer-review
Open AccessFile319 Downloads (Pure) -
Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships
Olubando, D., Hopton, C., Eden, J., Caswell, R., Thomas, N. L., Roberts, S. A., Venetucci, L. & Newman, W., 10 Mar 2020, In: Journal of Human Genetics. 65, p. 531-539Research output: Contribution to journal › Article › peer-review
Open AccessFile61 Downloads (Pure) -
Dysregulation of Ionic Homeostasis: Relevance for Cardiac Arrhythmias
Hopton, C., Venetucci, L. & Lettieri, M., 2018, Channelopathies in Heart Disease. . p. 127-144 18 p.Research output: Chapter in Book/Conference proceeding › Chapter
-
Not all ß-blockers are the same: a study to assess the potential efficacy of different ßblockers in the treatment of CPVT
Hopton, C., Tijsen, A., Maizels, L., Huber, I., Arbel, G., Gepstein, A., Gepstein, L., Newman, W. & Venetucci, L., 2018, (Unpublished).Research output: Contribution to conference › Poster
Prizes
-
British Heart Foundation Clinical Research Training Fellowship
Hopton, C. (Recipient), 2016
Prize: Fellowship awarded competitively
-
-
Royal College of Physicians Quincentennial Lecturer
Hopton, C. (Recipient), 2018
Prize: Prize (including medals and awards)
Activities
- 3 Oral presentation
-
Using human induced pluripotent stem cells to model a novel nonsense mutation of RYR2 and identify potential therapeutic agents for patients with CPVT.
Hopton, C. (Speaker)
16 Jul 2018Activity: Talk or presentation › Oral presentation › Research
-
Modelling a novel nonsense mutation of RYR2 using human induced pluripotent stem cells: beating disease with precision medicine.
Hopton, C. (Speaker)
15 Mar 2018Activity: Talk or presentation › Oral presentation › Research
-
Modelling a novel nonsense mutation of RYR2 using human induced pluripotent stem cells: beating disease with precision medicine.
Hopton, C. (Speaker)
1 Dec 2017Activity: Talk or presentation › Oral presentation › Research
Thesis
-
The molecular and electrophysiological characterisation of catecholaminergic polymorphic ventricular tachycardia.
Hopton, C. (Author), 11 Feb 2016Student thesis: Master of Philosophy
File -
Using human induced pluripotent stem cells to characterise a novel nonsense variant in RYR2
Hopton, C. (Author), Kimber, S. (Co Supervisor), Newman, W. (Co Supervisor) & Venetucci, L. (Main Supervisor), 6 Aug 2019Student thesis: Phd
File